Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy
Published Online: 2018-07-16
Journal: Molecular Imaging and Biology•Publisher: Springer Science and Business Media LLC
Authors: Andreas K. Buck•Constantin Lapa•Dirk O. Muegge•Frank Bengel•Harun Ilhan•Imke Schatka•László Papp•Markus Essler•Mehrbod S. Javadi•Norbert Zsótér•Peter Bartenstein•Ralph A. Bundschuh•Rudolf A. Werner•Sebastian Lehner•Takahiro Higuchi
